Back

Certain excipients have been exclusively developed for a few drug formulations that would go off-patent in the coming years. These excipients are Type IV DMF filed with USFDA & CHINA NMPA to aid to the NDA / ANDA filing planned by the drug formulators.

Excipients developed for specific formulations
Drug Formulation Excipient offered by Finar Regulatory Status/Grade

Amphoterecin B

di-Sodium succinate hexahydrate HP

USDMF, CDMF

Bendamustine

tert-Butanol HP

USDMF, CDMF

Acetonitrile HP

USDMF, CDMF

Acetone

USP-NF, Ph.Eur, BP, CDMF

Bortezomib

Acetonitrile HP

USDMF, CDMF

tert-Butanol HP

USDMF, CDMF

Buprenorphine patch

Levulinic acid

USDMF, CDMF

Busalfan

N,N-Dimethyl acetamide HP

USDMF, Ph.Eur, CDMF

PEG 400

USP, Ph.Eur

Carmustine

tert-Butanol HP

USDMF, CDMF

Cisatracurium besilate (Nimbex)

Benzene sulphonic acid HP

USDMF, CDMF

Cyclophosphamide

tert-Butanol HP

USDMF, CDMF

Decitabine

Acetonitrile HP

USDMF, CDMF

Dihydroergotamine

Methane sulphonic acid HP

USDMF, CDMF

Dimethyl fumarate

Fumaric acid

CDMF

Doxorubicin

tert-Butanol HP

USDMF, CDMF

Gadopentate dimeglumine

Diethylene triamine pentaacetic acid (Pentetic acid)

USP

Octreotide acetate

n-Heptane HP

USDMF

Octreotide capsule

Sodium caprate

Excipient Grade

Para-Effervescent tablets (Paracetamol)

Monosodium glycine carbonate

USDMF

Teriparatide

meta-Cresol

USP, Ph.Eur, BP, CDMF

**DMF under filing
*API ingredient

COA Product Catalogues Product Search Parenteral Applications
COA Product Catalogues Product Search Parenteral Applications